Advaxis, Inc. (NASDAQ: ADXS) stock price to trade stepped down -96.9% recently

Advaxis, Inc. (NASDAQ: ADXS) stock observed trading -96.88% off 52-week high price. On the other end, the stock has been noted 64.41% away from low price over the last 52-weeks. The stock disclosed a move of 7.15% away from 50 day moving average and -87.04% away from 200 day moving average. Moving closer, we can see that shares have been trading 6.03% off 20-day moving average. It has market cap of $8.17M.

Advaxis, Inc. (NASDAQ: ADXS), recently reported an update on its clinical pipeline and financial results for the fiscal third quarter ended July 31, 2019.

Fiscal Third Quarter Ended July 31, 2019 Financial Results

Research and development expenses for the third quarter of fiscal year 2019 were $7.1 mmm, contrast with $10.6 mmm for the third quarter of fiscal year 2018.

General and administrative expenses for the three months ended July 31, 2019 reduced about $1.7 mmm, or 35%, contrast to the same three-month period in 2018.

As of July 31, 2019, the Company had about $41.8 mmm in cash and cash equivalents.

The USA based company Advaxis, Inc. moved with change of 6.34% to $0.34 with the total traded volume of 3707173 shares in recent session versus to an average volume of 5700.21K. The stock was observed in the 5 days activity at 4.66%. The one month performance of stock was 0.06%. ADXS’s shares are at -18.65% for the quarter and driving a -96.15% return over the course of the past year and is now at -88.17% since this point in 2018.  Right now the stock beta is 3.2. The average volatility for the week and month was at 7.52% and 10.39% respectively. There are 24.22M shares outstanding and 24.22M shares are floated in market.

Dennis Taylor

Dennis Taylor –Health and Biotech I am Dennis Taylor with over 6 years of involvement with the market exchange industry, I am enthusiastic about Business and healthcare news, began my vocation as a writer at that point, later climbing my way up towards progress into senior positions. I can view myself as the spine behind the achievement and development of with a fantasy to grow the connections of the business on a worldwide scale. I am likewise a benefactor and a supervisor of the healthcare category. I encountered a critical investigation of organizations and extricated the most imperative data for our shareholder network.

Leave a Reply

Your email address will not be published.